The Phase III GRADIENT trial for relacorilant has missed its primary endpoint of improving SBP for Cushing's syndrome ...

Corcept Therapeutics Inc. (CORT), which posted strong financial results for the third quarter yesterday, is anticipating a ...

Sabrina Gomes, 24, has seen her skin get progressively darker since having a surgical procedure two years ago, but has had to fight in court to get the expensive treatment that could reverse it ...

Sparrow Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and immunology, today announced that the Phase 2 ...

A hormone associated with stress, cortisol, can significantly influence not only your health but also your appearance.

Virbac has launched Trilotab, the first chewable, flavoured and divisible trilostane tablet to treat Cushing’s syndrome in ...

A 51-year-old man in Binh Dinh Province, south-central Vietnam has died of A/H1pdm influenza infection that resulted in ...

Xeris is recognized for solid growth and innovative platforms. Learn more about XERS stock and why it's considered a Strong ...

KEY POINTS A 33-year-old woman presented to our outpatient endocrinology clinic with worsening hypertension (clinic blood pressure reading 169/112 mm Hg) despite treatment with perindopril 4 mg daily.

CORT beats on both earnings and sales in the third quarter of 2024. The company increases the revenue guidance for 2024. Stock falls in after-hours trading.

The news of Cushing's 'resurrection', despite his death in 1994, comes as Lucasfilm is being sued for using Cushing's likeness in Rogue One: A Star Wars Story, and Robert Downey Jr threatened to sue ...

But this year is different, because it coincides with Cushing’s childhood home being on the market, meaning you could actually move into the spaces were he spent his formative years. The three bedroom ...